Thermo Fisher Scientific has gone on to announce quite a major expansion of its Bioprocess Design Centers in Asia, hence deepening its investment within the rapidly advancing biopharmaceutical sector of the region. The company is now starting a new center in Hyderabad, India, and also enlarging its present facilities, which are located in Incheon, Korea, as well as Singapore, in order to speed up the process development and also offer specialized support for innovators all across the region.
It is worth noting that Asia continues to pop-up as a major engine when it comes to global biopharma innovation, which is driven by the rising demand in terms of biologics and vaccines as well as cell and gene therapies. The expanded network of Thermo Fisher gets with it technical expertise, advanced technologies as well as localised support which is much closer to customers so as to help make the development of life-changing therapies fast and hence the idea to expand the Bioprocess Design Centers in Asia makes a lot of sense. Thermo Fisher Scientific’s Senior Vice President and President, BioProduction, Daniella Cramp says that Asia continues to play an increasingly pivotal role when it comes to advancing innovation throughout the global biopharma sector. Through expanding their network in Korea, Singapore, and India, they are indeed bringing world-class infrastructure as well as expertise closer to their customers, thereby helping them to deliver high-quality biologics much faster and in a more cost-effective and sustainable way.
Apparently, the strengthened tri-hub network now goes on to support the crucial stages of bioprocess development.
Thermo Fisher also continues with its advancement of mass spectrometry and next-generation sequencing, as well as bioprocessing technologies, in order to support customers right from research to commercialization. By way of advanced manufacturing, strategic collaborations, and also targeted regional investments, they are indeed redefining what is possible when it comes to biologics production, opines President, Asia Pacific and Middle East, Africa, for Thermo Fisher Scientific, Tony Acciarito. He added that they are proud to go ahead and contribute to the transformation of the biopharma ecosystem of Asia and also help their customers bring the life-changing therapies to patients throughout Asia and even beyond.
